India's Metropolis Healthcare hits near 2-yr high on revenue, margin jump

Metropolis Healthcare

12/04/2024 06:41

** Shares of Metropolis Healthcare  METP.NS  rise as much as
7.4% to 1,933.50 rupees, highest since May 18, 2022
    ** Diagnostic services co says revenue grew ~15% Y/Y in
Q4FY24 
    ** Adds, EBITDA margins show consistent upward trend both
Q/Q and Y/Y, driven by higher volumes, price increase
    ** Stock on track to gain for fifth straight session
    ** More than 1.6 mln shares traded as of 10:51 a.m. IST,
5.6x their 30-day moving avg; busiest day yet since Feb. 6
    ** Mean rating of 13 analysts is "hold"; median PT 1,670
rupees, while bigger peer Dr. Lal Pathlabs  DLPA.NS  is "sell" -
LSEG data 
    ** METP last up 4.3%, adding to YTD gains of ~11.9%; DLPA
down 8%

 (Reporting by Meenakshi Maidas in Bengaluru)
 ((meenakshi.maidas@thomsonreuters.com;))